Keigo Machida

6.5k citations
88 papers · 4.7k indexed · h-index 39
Topics
Hepatitis C virus research (27 papers)Cancer, Hypoxia, and Metabolism (14 papers)Liver Disease Diagnosis and Treatment (14 papers)
Partner nations
United StatesJapanTaiwan

In The Last Decade

Keigo Machida

88 papers receiving 4.7k citations

Peers

Keigo Machida
Comparison fields: 5 of 132
  • Epidemiology 1.9k
  • Molecular Biology 1.8k
  • Hepatology 1.5k
  • Oncology 769
  • Immunology 722
Replace Robert Steele with:
Robert Steele United States
Achim Weber Switzerland
Tonino Alonzi Italy
Akinori Kasahara Japan
Johannes G. Bode Germany
Mark D. Gorrell Australia
Hisashi Ishida Japan
Sidong Xiong China
Jie Lu China
Matteo Iannacone Italy
Keigo Machida relative to Robert Steele United States Robert Steele's profile →
Citations per field
00.5×1.5×1.8×
Robert Steele · 1×
Citations per year

Countries citing papers authored by Keigo Machida

Since Specialization
Citations

This map shows the geographic impact of Keigo Machida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keigo Machida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keigo Machida more than expected).

Fields of papers citing papers by Keigo Machida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keigo Machida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keigo Machida. The network helps show where Keigo Machida may publish in the future.

Co-authorship network of co-authors of Keigo Machida

This figure shows the co-authorship network connecting the top 25 collaborators of Keigo Machida. A scholar is included among the top collaborators of Keigo Machida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keigo Machida. Keigo Machida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 9
3 1
4 38
5 9
6 9
7 20
8 13
9 310
10 14
11 21
12 8
13 6
14 82
15 31
16 46
17 78
18 110
19 86
20 82

About Keigo Machida

Keigo Machida is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 88 papers that have together received 4.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Liver Disease Diagnosis and Treatment (14 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (1.9k citations) and Cancer Research (714 citations). Keigo Machida has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Michael M. C. Lai, Vicky M.-H. Sung, Hidekazu Tsukamoto, Jing‐hsiung James Ou, Chia‐Lin Chen, King-Song Jeng, Alexandra M. Levine, Chao-Kuen Lai, Vasu Punj and Michael M. C. Lai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026